Development of the Actinide Decorporation Agent HOPO-101 for Broad Spectrum Heavy Metal Exposure
Inactive
Contract Opportunity
Notice ID
75A50124C00062
Contract Line Item Number
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Award Details
- Contract Award Date: Sep 30, 2024
- Contract Award Number: 75A50124C00062
- Task/Delivery Order Number:
- Contractor Awarded Unique Entity ID: H5MWN5ZBXQ98
- Contractor Awarded Name: HOPO THERAPEUTICS, INC.
- Contractor Awarded Address: Berkeley, CA 94704 USA
- Base and All Options Value (Total Contract Value): $226,309,811.00
General Information
- Contract Opportunity Type: Award Notice (Original)
- Original Published Date: Oct 07, 2024 10:59 am EDT
- Inactive Policy: 15 days after contract award date
- Original Inactive Date: Oct 15, 2024
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Place of Performance: Berkeley , MOUSA
Description
This contract was awarded as a Cost Contract based on the research and development nature of the contract. Dueto the uncertainties involved in the contract performance related to the requirements, the Government is not able to estimate with sufficient accuracy the level of efforts or costs for the work.
Attachments/Links
Contact Information
Contracting Office Address
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
Primary Point of Contact
- BARDA-BAA@hhs.gov
- BARDA-BAA@hhs.gov
Secondary Point of Contact
History
- Oct 15, 2024 11:55 pm EDTAward Notice (Original)
- May 31, 2024 12:17 pm EDTSolicitation (Updated)